Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme

Hartwig P. Huemer*, Birgit Strobl, Norbert Nowotny

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Agricultural and Biological Sciences

Nursing and Health Professions